Articles 7 Questions: Jörg Land on the first reimbursed mobile app in... Jörg Land talks about the approval process for a new app technology for treating tinnitus, the first ever to be reimbursed in Germany
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.